glp 1 tachycardia GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease Differential effects of glucagon-like peptide-1
Description
A board certified doctor-guided weight loss program with FDA-approved GLP-1 medications, nutrition guidance and support in NJ.
Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)
Discover the evidence, potential causes, and when to seek medical advice
Dr Gregom Sng and Dr Chew Chun Yang from Parkway Shenton explain whos suitable, how these medications work, and what results to expect.
After their success in the obesity field, GLP-1 agonists are gaining interest in addiction treatment
